These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 1430001
1. Measurement of halofantrine and its major metabolite desbutylhalofantrine in plasma and blood by high-performance liquid chromatography: a new methodology. Mberu EK, Muhia DK, Watkins WM. J Chromatogr; 1992 Oct 02; 581(1):156-60. PubMed ID: 1430001 [Abstract] [Full Text] [Related]
3. A simplified liquid chromatography assay for the quantitation of halofantrine and desbutylhalofantrine in plasma and identification of a degradation product of desbutylhalofantrine formed under alkaline conditions. Humberstone AJ, Currie GJ, Porter CJ, Scanlon MJ, Charman WN. J Pharm Biomed Anal; 1995 Mar 02; 13(3):265-72. PubMed ID: 7619886 [Abstract] [Full Text] [Related]
4. Analysis of the antimalarial drug halofantrine and its major metabolite N-desbutylhalofantrine in human plasma by high performance liquid chromatography. Kolade YT, Babalola CP, Scriba GK. J Pharm Biomed Anal; 2006 Apr 11; 41(1):315-9. PubMed ID: 16337357 [Abstract] [Full Text] [Related]
7. Determination of halofantrine and its main metabolite desbutylhalofantrine in rat plasma by high-performance liquid chromatography with on-line UV irradiation and peroxyoxalate chemiluminescence detection. Amponsaa-Karikari A, Kishikawa N, Ohyama K, Nakashima K, Kuroda N. Biomed Chromatogr; 2009 Jan 11; 23(1):101-6. PubMed ID: 18823073 [Abstract] [Full Text] [Related]
8. Comparison of capillary whole blood, venous whole blood, and plasma concentrations of mefloquine, halofantrine, and desbutyl-halofantrine measured by high-performance liquid chromatography. Ter Kuile FO, Teja-Isavatharm P, Edstein MD, Keeratithakul D, Dolan G, Nosten F, Phaipun L, Webster HK, White NJ. Am J Trop Med Hyg; 1994 Dec 11; 51(6):778-84. PubMed ID: 7810811 [Abstract] [Full Text] [Related]
9. An improved high-performance liquid chromatographic method for the simultaneous measurement of halofantrine and desbutylhalofantrine in human serum. Keeratithakul D, Teja-Isavadharm P, Shanks GD, Webster HK, Edstein MD. Ther Drug Monit; 1991 Jan 11; 13(1):64-8. PubMed ID: 2057994 [Abstract] [Full Text] [Related]
15. Direct determination of the enantiomers of halofantrine and its pharmacologically active metabolite N-desbutylhalofantrine by high-performance liquid chromatography. Terefe H, Blaschke G. J Chromatogr; 1993 Jun 02; 615(2):347-51. PubMed ID: 8335715 [Abstract] [Full Text] [Related]
17. The determination of the enantiomers of halofantrine and monodesbutylhalofantrine in plasma and whole blood using sequential achiral/chiral high-performance liquid chromatography. Gimenez F, Aubry AF, Farinotti R, Kirkland K, Wainer IW. J Pharm Biomed Anal; 1992 Jun 02; 10(2-3):245-50. PubMed ID: 1391105 [No Abstract] [Full Text] [Related]
18. Pharmacokinetics of halofantrine in the rat: stereoselectivity and interspecies comparisons. Brocks DR, Toni JW. Biopharm Drug Dispos; 1999 Apr 02; 20(3):165-9. PubMed ID: 10211870 [Abstract] [Full Text] [Related]
19. Pharmacokinetics of halofantrine in Thai patients with acute uncomplicated falciparum malaria. Karbwang J, Milton KA, Na Bangchang K, Ward SA, Edwards G, Bunnag D. Br J Clin Pharmacol; 1991 Apr 02; 31(4):484-7. PubMed ID: 2049260 [Abstract] [Full Text] [Related]